Beijing Tong Ren Tang Chinese Medicine Company Limited (03613) released a monthly return for the equity issuer covering January 2026. According to the filing dated 3 February 2026, there were no changes in authorized or issued share capital for the period. The total number of issued shares remained at 837,100,000, with no treasury shares recorded.

The announcement indicates that the company complied with the required public float threshold of 25%. There were no reported movements regarding share options, warrants, convertible securities, or other instruments related to issuing new shares. No changes were noted in any other share classes, Hong Kong Depositary Receipts, or treasury-related transactions.